Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection therapy produces rapid weight loss by reducing appetite and slowing gastric emptying, but studies show that 20–30% of lost weight can come from lean muscle tissue if protein intake and exercise remain inadequate. Adding creatine supplementation may offset this loss by supporting muscle protein synthesis and cellular energy production during a caloric deficit.

How Semaglutide Affects Muscle Mass During Weight Loss

GLP-1 receptor agonists like semaglutide decrease hunger signals and food intake, creating a caloric deficit needed for weight reduction. However, the body mobilizes both fat and muscle tissue for energy when calorie intake drops sharply. Research published in obesity journals indicates that patients on GLP-1 therapy who do not actively support muscle maintenance through resistance training and adequate protein lose proportionally more lean mass compared to those following structured nutrition plans.

The risk escalates when daily protein intake falls below 1.2 grams per kilogram of body weight or when exercise volume decreases. PlexusDx patients beginning semaglutide injection therapy are advised to establish a baseline fitness routine and track protein consumption to minimize muscle loss while maximizing fat reduction.

Creatine Monohydrate as a Muscle-Sparing Supplement

Creatine monohydrate is one of the most studied dietary supplements in sports nutrition. It works by increasing phosphocreatine stores in muscle cells, which fuel high-energy contractions during resistance exercise and enhance ATP (adenosine triphosphate) regeneration. Clinical trials show that creatine supplementation combined with resistance training increases lean muscle mass and strength even during caloric restriction.

A standard protocol involves a loading phase of 20 grams daily divided into four doses for 5–7 days, followed by a maintenance phase of 3–5 grams daily. This approach has demonstrated safety across decades of research in healthy populations. When combined with semaglutide therapy, creatine may provide a synergistic benefit: the medication suppresses appetite while the supplement supports muscle energy metabolism and protein synthesis during workouts.

Protein, Creatine, and Exercise: The Complete Muscle-Preservation Strategy

Creatine alone does not prevent muscle loss; it amplifies the protective effect of resistance training and adequate protein intake. Patients on semaglutide injection should prioritize 1.2–1.6 grams of protein per kilogram of body weight daily, distributed across 4–5 meals to maximize muscle protein synthesis. This elevated protein target becomes more critical during rapid weight loss when the anabolic environment is naturally suppressed.

Resistance training performed 3–4 days per week activates the mechanical and metabolic signals that preserve muscle tissue. Creatine supplementation enhances the force-generating capacity and recovery of these muscles, making each workout session more effective at building or maintaining lean mass. PlexusDx recommends that patients beginning semaglutide therapy consult a registered dietitian or certified strength coach to design a personalized nutrition and exercise plan that incorporates creatine when appropriate.

Safety Considerations and Hydration with Semaglutide and Creatine

Creatine monohydrate increases intramuscular water retention, which can elevate creatinine levels on bloodwork without indicating kidney dysfunction. Patients taking semaglutide injection should maintain consistent hydration—typically 2.5–3.5 liters of water daily—because both semaglutide and creatine require adequate fluid for optimal function. Dehydration risk may be higher early in semaglutide treatment when nausea and reduced food intake can occur.

Individuals with existing kidney disease, diabetes requiring insulin, or those taking medications affecting renal function should consult their physician before starting creatine. PlexusDx semaglutide injection patients with normal kidney function and no contraindications can safely use creatine monohydrate; however, baseline and periodic renal panel monitoring remains a standard of care for anyone undergoing significant weight loss therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will creatine cause water weight gain while I am on semaglutide?

Creatine pulls water into muscle cells, not subcutaneous tissue, so the weight gain appears on the scale but does not represent fat accumulation. This intramuscular water is temporary and can actually improve muscle strength and appearance.

Does creatine interact with semaglutide or affect GLP-1 therapy?

No direct pharmacological interaction exists between creatine monohydrate and semaglutide. Both compounds work through separate metabolic pathways. Creatine supports muscle energy production and protein synthesis, while semaglutide suppresses appetite through GLP-1 receptor signaling in the brain and gut.

How much does semaglutide injection cost at PlexusDx?

PlexusDx offers compounded semaglutide injection starting at $149 per month across three commitment tiers. Your dose may need to go up as your body responds to therapy, but your price will not change. All medications come from licensed 503A compounding pharmacies, and the service is available in all 50 states without insurance or membership fees.

Is creatine safe for long-term use during extended semaglutide treatment?

Creatine monohydrate has a strong safety record across 20+ years of clinical research in healthy individuals. Long-term supplementation at standard doses (3–5 grams daily) does not damage kidneys or liver in people with normal baseline renal function.

Can the PlexusDx Precision Peptide Genetic Test help me personalize my muscle-preservation plan?

PlexusDx Precision Peptide Genetic Test ($99 add-on after the first month of semaglutide treatment) analyzes peptide-pathway variants including GLP1R and MC4R that influence appetite regulation and metabolic response.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves